Log In Sign up
The largest database of trusted experimental protocols

Recombinant human plac1

Manufactured by R&D Systems
Visit Supplier
Sourced in United States

Recombinant human PLAC1 is a protein produced using recombinant DNA technology. PLAC1 is a placenta-specific gene that plays a role in placental development and function.

Automatically generated - may contain errors

Lab products found in correlation

Ly294002, by Cell Signaling Technology (3 mentions) Phospho nf κb p65 ser536, by Cell Signaling Technology (3 mentions) Anti human plac1 antibodies, by R&D Systems (3 mentions)

3 protocols using recombinant human plac1

1

Investigating PLAC1 Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human PLAC1 and anti-human PLAC1 antibodies were provided by R&D System Inc. (Minneapolis, Minnesota, USA). LY294002 (PI3K inhibitor) was ordered from Cell Signaling Technology (Beverly, Massachusetts, USA). The Akt inhibitor was purchased from BioVision (Mountain View, California, USA). The Akt, phospho-Akt (Ser473), PI3K p85, phospho-PI3K p85 (Tyr 458)/p55 (Tyr199), NF-κB p65, and phospho-NF-κB p65 (Ser536) antibodies were purchased from Cell Signaling Technology (Mountain View).
Ma J., Li L., Du J., Pan C., Zhang C, & Chen Y. (2020). Placenta-specific protein 1 enhances liver metastatic potential and is associated with the PI3K/AKT/NF-κB signaling pathway in colorectal cancer. European Journal of Cancer Prevention, 30(3), 220-231.
+ Open protocol
+ Expand
2

Investigating PLAC1 Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human PLAC1 and anti-human PLAC1 antibodies were provided by R&D System Inc. (Minneapolis, MN, USA). LY294002 (PI3K inhibitor) was ordered from Cell Signaling Technology (Beverly, MA, USA). The Akt inhibitor was purchased from BioVision (Mountain View, CA, USA). The Akt, phospho-Akt (Ser473), PI3K p85, phospho-PI3K p85 (Tyr 458)/p55 (Tyr199), NF-κB p65, and phospho-NF-κB p65 (Ser536) antibodies were purchased from Cell Signaling Technology (Mountain View, CA).
Ma J., Li L., Du J., Pan C., Zhang C., & Chen Y. (2020). Placenta-Specific Protein 1 Enhances Metastatic Potential and is Associated with the PI3K/AKT/NF-κB Signaling Pathway in Colorectal Cancer.
+ Open protocol
+ Expand
3

Investigating PLAC1 Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human PLAC1 and anti-human PLAC1 antibodies were provided by R&D System Inc. (Minneapolis, MN, USA). LY294002 (PI3K inhibitor) was ordered from Cell Signaling Technology (Beverly, MA, USA). The Akt inhibitor was purchased from BioVision (Mountain View, CA, USA). The Akt, phospho-Akt (Ser473), PI3K p85, phospho-PI3K p85 (Tyr 458)/p55 (Tyr199), NF-κB p65, and phospho-NF-κB p65 (Ser536) antibodies were purchased from Cell Signaling Technology (Mountain View, CA).
Ma J., Li L., Du J., Pan C., Zhang C., & Chen Y. (2020). Placenta-Specific Protein 1 Enhances Liver Metastatic Potential and is Associated with the PI3K/AKT/NF-κB Signaling Pathway in Colorectal Cancer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!